Outcomes with Pre-Emptive Rituximab (pre-R) Treatment for Epstein-Barr Viremia (EBV) after Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
2017 ◽
Vol 23
(3)
◽
pp. S279-S280
◽
2010 ◽
Vol 12
(4)
◽
pp. 284-291
◽
2018 ◽
Vol 23
(1)
◽
pp. 15-24
2010 ◽
Vol 30
(6)
◽
pp. 554-558
◽